SMALES KELLY sold 5.4% of their position (4K shares) of TRANSPHORM, INC. on the open market
Open‑market sale worth $19.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/24/2024ACC: 0001415889-24-014469
-4K
Net shares
Net seller
$19.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4K
Price / share
$4.89
Trade value
$19.55K
% of position
5.4%
5/22/2024
73.67K→69.68K
Total
Net shares
−4K
Net value
-$19.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/22/2024 | S · Sale | −4K | $4.89 | $19.55K | 5.4% | 73.67K | 69.68K |
| Total | −4K | -$19.55K | ||||||
Derivative Transactions0
No derivative transactions reported